Stock Market Today, Feb: ImmunityBio Up on Anktiva EU OK
ImmunityBio sails higher after the EU green lights ANKTIVA for bladder cancer, igniting waves across biotech stocks. ...
What does an index reading tell you about the market? It reflects price action and momentum, offering clues to potential trends and turning points.
28,481 articlesImmunityBio sails higher after the EU green lights ANKTIVA for bladder cancer, igniting waves across biotech stocks. ...
A historic step: Paxos earns SEC clearance to operate as a registered clearing agency. This milestone could reshape c...
A single quarterly filing can rewrite a fund’s star players. Tepper’s Appaloosa appears to have shifted away from NVI...
Quantum tech is finally moving from labs to portfolios. This article breaks down why d-wave quantum shares soaring ha...
AST SpaceMobile faced a sharp weekly drop after announcing a large convertible debt raise. This article explains why ...
Navitas Semiconductor has ridden a wave of AI infrastructure enthusiasm as data-center spending strengthens. This art...
The allure of in-person auditions can draw massive crowds—and big financial and safety risks. Cenat’s streamer univer...
Celebrity engagements often trigger more than wedding planning. This piece breaks down the financial implications of ...
When regulators revoke a facility’s license, families face tough financial and care decisions. This article breaks do...
Could Bloom Energy ride AI demand like Nvidia did? This comprehensive guide weighs the parallels, the risks, and prac...
As biotech earnings season unfolds, Precigen (PGEN) 2025 earnings take center stage. This guide breaks down what to m...
As Zoom prepares for 2026, investors want to know how the company will grow revenue, expand margins, and win with AI....